# Efficacy of Chemopreventive Agents on Disease-free and Overall Survival in Patients With Pancreatic Ductal Adenocarcinoma: The CAOS Study

> **NCT04245644** · — · UNKNOWN · sponsor: **Massimo Falconi** · enrollment: 800 (actual)

## Conditions studied

- Disease Free Survival
- Overall Survival
- Pancreatic Cancer

## Interventions

- **BEHAVIORAL:** use of targeted drugs such as aspirin, B-Blockers, Metformin, ACE-inhibitors, Statins

## Key facts

- **NCT ID:** NCT04245644
- **Lead sponsor:** Massimo Falconi
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-03-02
- **Primary completion:** 2023-12-31
- **Final completion:** 2024-12-31
- **Target enrollment:** 800 (ACTUAL)
- **Last updated:** 2024-03-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04245644

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04245644, "Efficacy of Chemopreventive Agents on Disease-free and Overall Survival in Patients With Pancreatic Ductal Adenocarcinoma: The CAOS Study". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04245644. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*